Pacific Biosciences Of California (PACB) Construction in Progress (2016)
Pacific Biosciences Of California's quarterly Construction in Progress came in at $5.8 million in Q4 2016.
Pacific Biosciences Of California has reported Construction in Progress for 1 years, with the latest figure at $5.8 million in Q4 2016.
- For the quarter ending Q4 2016, Construction in Progress changed N/A year-over-year to $5.8 million; the trailing twelve-month figure through Dec 2016 stood at $5.8 million (changed N/A YoY), and the FY2016 full-year result was $5.8 million, changed N/A from the prior year.
- Construction in Progress for Q4 2016 stood at $5.8 million.
- The five-year high for Construction in Progress was $5.8 million in Q4 2016, with the low at $5.8 million in Q4 2016.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.12 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 509.50 Mn |
| 10 | Pacific Biosciences Of California | 481.66 Mn | 205.70 Mn | 12.84 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 5.80 Mn |